Polyphenols in Metabolic Diseases.
Amin GasmiPavan Kumar MujawdiyaSadaf NoorRoman LysiukRoman DarmohraySalva PiscopoLarysa LenchykHalyna AntonyakKateryna DehtiarovaMariia ShanaidaAlexandr PolishchukVolodymyr ShanaidaMassimiliano PeanaGeir BjørklundPublished in: Molecules (Basel, Switzerland) (2022)
Polyphenols (PPs) are a large group of phytochemicals containing phenolic rings with two or more hydroxyl groups. They possess powerful antioxidant properties, multiple therapeutic effects, and possible health benefits in vivo and in vitro, as well as reported clinical studies. Considering their free-radical scavenging and anti-inflammatory properties, these substances can be used to treat different kinds of conditions associated with metabolic disorders. Many symptoms of metabolic syndrome (MtS), including obesity, dyslipidemia, atherosclerosis, elevated blood sugar, accelerating aging, liver intoxication, hypertension, as well as cancer and neurodegenerative disorders, are substantially relieved by dietary PPs. The present study explores the bioprotective properties and associated underlying mechanisms of PPs. A detailed understanding of these natural compounds will open up new opportunities for producing unique natural PP-rich dietary and medicinal plans, ultimately affirming their health benefits.
Keyphrases
- metabolic syndrome
- anti inflammatory
- public health
- healthcare
- insulin resistance
- mental health
- blood pressure
- health information
- type diabetes
- cardiovascular disease
- oxidative stress
- papillary thyroid
- minimally invasive
- weight loss
- uric acid
- health promotion
- weight gain
- drinking water
- squamous cell carcinoma
- young adults
- squamous cell
- adipose tissue
- skeletal muscle
- physical activity
- climate change